S1 Text. Materials and Methods
Viral RNA extraction, reverse transcription, PCR amplification and purification of full length gag, pol and nef. The QIAamp Viral RNA extraction kit (Qiagen, Limburg, Netherlands) was used to purify viral RNA from 140μl of peripheral blood plasma following the manufacturer's instructions. Purified RNA was stored at -80˚C until use. HIV-1 gag, pol and nef sequences were amplified by nested PCR(1). The Titan One tube RT-PCR Kit (Roche, Basel, Switzerland) was used for reverse transcription (RT) and first round PCR amplification of gag, pol and nef in a single reaction. The Expand High Fidelity PCR System (Roche) was used to amplify the 1 st round PCR products. All primers for PCR and sequencing (S2 Table) were synthesised by MWG Operon (Huntsville, AL, USA). For RT of gag and 1st round amplification, in each 25µL reaction, 1x reaction buffer, 200µM dNTPs, 0.5mM of each primer CTLGagOF and CTLGag OR (Table S2) , 5U of RNAse inhibitor, 0.5µL of enzyme mix and 5µL of extracted viral RNA were used. RT was carried out at 50˚C for 30 min, followed by 94˚C for 2 min, followed by 10 cycles of 94˚C for 15 sec, 54˚C for 30 sec and 68˚C for 2 min, followed by 19 cycles of 94˚C for 15 sec, 54˚C for 30 sec and 68˚C for 2 minutes with 5 sec increments at each cycle and a final extension at 68˚C for 7 min. For 2nd round gag amplification, nested primers CTLGagIF and CTLGagIR (Table 2) at 0.3µM were used in a 50µL reaction together with 1X reaction buffer, 200µM dNTPs, 0.75µL of enzyme mix and 1uL of first round product as template. The reaction proceeded under the same conditions as the 1st round reaction omitting the RT step. For pol, the 1st and 2nd round reactions were set up with primers pairs CTLPolOF and CTLPolOR, and CTLPolIF and CTLPolIR (S2 Table) respectively at 0.2µM each in both reactions. All other reaction components were the same as detailed for gag for both reactions. 1st and 2nd round reactions proceeded under the same cycling conditions as for gag except the first two elongation steps proceeded for 3 min. For nef, the 1st and 2nd round reactions were set up with primers pairs CTLNefOF and CTLNefOR, and CTLNefIF and CTLNefIR (Table S2) respectively at 0.2µM each in both reactions. In the 1st round reaction RT proceeded at 50˚C
for 30 min and 94˚C for 2 min then 40 cycles of 94˚C for 15 sec, 54˚C for 30 sec and 72˚C
for 2 min with a final extension at 72˚C for 7 min. The second round reaction proceeded under the same cycling conditions as the 1st round omitting the RT step. Nested product were resolved on a 1% agarose gel. Amplicons yielding a single sized band were directly purified using the PCR purification Kit (Qiagen). Amplicons resulting in multiple sized bands were gel purified using the QIAquick Gel Extraction Kit (Qiagen). Purified DNA was stored at -
20˚C.
Recombinant subtype characterisation. A concatenated alignment (5009 bp) of near full length gag-pol-nef infant sequences and the full HIV-1 LANLDB subtype reference alignment was made and gap stripped. A sliding window of 400bp was used with increments of 50bp. Bootscan analysis was carried out using the neighbour-joining method with the Kimura 2-parameter model, a transition/transversion rate of 2.0 and with 100 bootstrap replicates for each sliding window. Breakpoint coordinates relative to HXB2 were identified using the HIV Sequence Locator Tool(2) at the LANLDB. The Recombinant HIV-1 Drawing Tool(2) from the LANLDB was used to depict the breakpoint positions on the HIV-1 genome. 12 (63) 44 ( recombinant; the A1 subtype corresponded to the 3' region of pol and this was also found for nef. 
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